Abiopharma

Belite Bio to Participate in the Deutsche Bank ADR Virtual Investor Conference

Reviva to Participate in the Spartan Capital Securities Second Annual Investor Conference

IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site

Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform

Zevra Therapeutics to Participate in the Guggenheim Healthcare Innovation Conference

Aclaris Therapeutics to Participate in Three November Healthcare Conferences

ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference

Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group

OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th

Fortive Reports Third Quarter 2025 Results